Asia Pacific Wearable Medical Device  Market Research Report- Forecast To 2027

Asia Pacific Wearable Medical Device, By Type (Diagnostic & Monitoring, Vital Sign Monitoring And Therapeutic Devices) By Application (Fitness, Blood Pressure Monitoring, Heart Rate Monitoring, Weight Monitoring) By End Users (Sports Person, Patients) - Forecast To 2027

ID: MRFR/MED/0186-HCR | February 2021 | Region: Global | 80 pages

Market Scenario


Wearable devices are easy to use, cordless, and can provide information about various factors such as heart rate, blood pressure, weight, sleeping habits, and others. Increasing cases of chronic conditions such as obesity, heart problems, breathing problems, and many more such diseases drive the growth of the Asia Pacific market. In recent years, the demand for wearable medical devices has increased since they provide real time data about individual’s activities such as heart count and the number of steps taken while walking. This trend is increasing because the wearable device can be easily linked to the smartphones fitness applications. The demand for these devices is majorly attributed to the increasing awareness among health consciousness people and sports men. In Asia Pacific, large pool of population have lifestyle diseases such as diabetes and obesity, which has increased the risk of cancer. On the other hand, high cost of these devices may act as a restrain for the growth of this market.


The Asia Pacific wearable medical devices market is expected to grow at a CAGR of ~15.94% during the forecast period 2017-2023.


Market Synopsis of Wearable Medical Device Market:


Figure 1: Market Synopsis
Asia Pacific Wearable Medical Device Market


Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview


Key Players for Wearable Medical Device Market


Some of the major players in this market are Abbott (U.S.), Baxter (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), Boston Scientific (U.S.), Cardinal Health (U.S.), General Electric Company (U.S.), Johnson & Johnson (U.S.), Medtronic (U.S.), Koninklijke Philips N.V. (Netherland), Siemens (U.S.), and Stryker (U.S.)


Segments


Asia Pacific wearable medical devices market has been segmented on the basis of types, applications, and end users.


On the basis of types, the market is segmented into diagnostic, vital sign monitoring, and therapeutic devices.


 On the basis of applications, it is segmented into fitness devices, blood pressure monitoring devices, heart rate monitoring devices, weight monitoring devices, and others.


On the basis of the end users, the market is segmented as sports person, patients, and others.


Figure 2: Asia Pacific Wearable Medical Device Market Share by Country, 2016 (%)
Asia Pacific Wearable Medical Device Market -


Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview


 


 


Regional Analysis of Wearable Medical Device Market


Asia Pacific region is divided into countries namely India, Japan, China, Republic of Korea, Australia, and Rest of Asia Pacific. Countries in Asia Pacific have a great potential for the growth of this market. Asia Pacific market for medical devices is driven by innovative technology for continuous monitoring of health status of a patient in hospitals as well as sportsmen and athletes. The demand for easy to use wearable medical devices is increasing in China and India.  Furthermore, increasing prevalence of cardiovascular diseases, diabetes and obesity drive the market growth. Growing trend in the use of wearable medical devices such as smart watches also influences the growth of the market.


China is the largest market for these devices due to increasing awareness regarding fitness and health, technological advancement and increasing prevalence of diabetes and heart diseases. According to the World Health Organization, the number of annual cardiovascular events account to 41% of total deaths in China, while number of diabetic patients in India was about 65 million in 2016, which will reach to 101 million by 2030. According to the International Diabetes Federation, about 420 million adult population worldwide was suffering from diabetes in 2016, which is increasing at the rate of 8.4% per year and is expected to reach 625 million by 2040.


According to the Lancet study, China, and India are among the top two countries with a high number of diabetic population. The number of diabetic population has increased from 20.4 million in China in 1980 to 102.9 million in 2014, and the rise has been equally dramatic in India from 11.9 million in 1980 to 64.5 million in India. By 2030, both of the countries together will have about half a billion diabetic population.


India is the second largest market owing to increasing prevalence of chronic disease such as diabetes and chronic heart diseases, which is expected to be the fastest growing market over the forecast period. Additionally, increasing demand for heart rate and blood glucose monitoring devices drives the market in India.


Japan is the third largest market for wearable medical devices. Whereas the market has shown steady growth is Australia.


Intended Audience



  • Wearable Medical Device Manufacturers

  • Wearable Medical Device Suppliers & Distributers

  • Device Parts Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities 



Speak to Analyst Ask for Customization

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Asia Pacific Wearable Medical Device Market, by Type

6.1 Introduction

6.2 Diagnostic

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Vital Sign Monitoring

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Therapeutic Devices

6.4.1 Market Estimates & Forecast, 2020-2027

7. Asia Pacific Wearable Medical Device Market, by Application

7.1 Introduction

7.2 Fitness

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Blood Pressure Monitoring

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Heart Rate Monitoring

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Weight Monitoring

7.5.1 Market Estimates & Forecast, 2020-2027

8. Asia Pacific Wearable Medical Device Market, by End User

8.1 Introduction

8.2 Sports Person

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Patients

8.3.1 Market Estimates & Forecast, 2020-2027

9. Asia Pacific Wearable Medical Device Market, by Region

9.1 Introduction

9.2 Asia Pacific

9.2.1 Japan

9.2.2 China

9.2.3 India

9.2.4 Australia

9.2.5 Republic of Korea

9.2.6 Rest of Asia Pacific

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

11 Company Profiles

11.1 Abbott

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Baxter

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 B. Braun Melsungen AG

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Becton Dickinson Company

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 BOSTON SCIENTIFIC

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Cardinal Health

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Device Industry

13 Appendix

LIST OF TABLES

Table 1 Wearable Medical Device Industry Synopsis, 2020-2027

Table 2 Asia Pacific Wearable Medical Device Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Asia Pacific Wearable Medical Device Market by Region, 2020-2027, (USD Million)

Table 4 Asia Pacific Wearable Medical Device Market by Types, 2020-2027, (USD Million)

Table 5 Asia Pacific Wearable Medical Device Market for diagnostic, 2020-2027, (USD Million)

Table 6 Asia Pacific Wearable Medical Device Market for vital sign monitoring, 2020-2027, (USD Million)

Table 7 Asia Pacific Wearable Medical Device Market for therapeutic devices, 2020-2027, (USD Million)

Table 8 Asia Pacific Wearable Medical Device Market by Application, 2020-2027, (USD Million)

Table 9 Asia Pacific Wearable Medical Device Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Wearable Medical Device Market

Figure 3 Segmentation Market Dynamics for Eye Care Supplements Market

Figure 4 Asia Pacific Wearable Medical Device Market Share, by Type, 2020

Figure 5 Asia Pacific Wearable Medical Device Market Share, by Application, 2020

Figure 6 Asia Pacific Wearable Medical Device Market Share, by End Users, 2020

Figure 7 Asia Pacific Wearable Medical Device Market Share, by Region, 2020

Figure 8 Asia Pacific Wearable Medical Device Market: Company Share Analysis, 2020 (%)

Figure 9 Abbott: Key Financials

Figure 10 Abbott: Segmental Revenue

Figure 11 Abbott: Geographical Revenue

Figure 12 Baxter: Key Financials

Figure 13 Baxter: Segmental Revenue

Figure 14 Baxter: Geographical Revenue

Figure 15 B. Braun Melsungen AG: Key Financials

Figure 16 B. Braun Melsungen AG: Segmental Revenue

Figure 17 B. Braun Melsungen AG: Geographical Revenue

Figure 18 Becton Dickinson Company: Key Financials

Figure 19 Becton Dickinson Company: Segmental Revenue

Figure 20 Becton Dickinson Company: Geographical Revenue

Figure 21 Merck & Co., Inc: Key Financials

Figure 22 Merck & Co., Inc: Segmental Revenue

Figure 23 Merck & Co., Inc: Geographical Revenue

Figure 24 BOSTON SCIENTIFIC: Key Financials

Figure 25 BOSTON SCIENTIFIC: Segmental Revenue

Figure 26 BOSTON SCIENTIFIC: Geographical Revenue

Figure 27 Cardinal Health: Key Financials

Figure 28 Cardinal Health: Segmental Revenue

Figure 29 Cardinal Health: Geographical Revenue